Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 454 shares. Based on an average daily volume of 422 shares, the short-interest ratio is currently 1.1 days.
Hikma Pharmaceuticals Price Performance
OTCMKTS HKMPY remained flat at $44.40 on Friday. The company’s stock had a trading volume of 272 shares, compared to its average volume of 1,245. Hikma Pharmaceuticals has a 52 week low of $31.80 and a 52 week high of $49.31. The company’s 50-day moving average price is $43.24 and its two-hundred day moving average price is $40.78.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC is a global pharmaceutical company headquartered in London, United Kingdom. Founded in 1978 by Samih Darwazah in Jordan, the company develops, manufactures and markets a broad range of prescription medicines for healthcare providers and patients.
Hikma operates through three principal businesses: Injectables, Generics and Branded Medicines. Its portfolio includes hospital injectable products, specialty and generic medicines, and branded pharmaceutical products in areas such as respiratory care, cardiovascular treatment, pain management, anti-infectives and central nervous system therapies.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
- Palantir’s Potential Next Catalyst After Retail Profit-Taking
- Morgan Stanley Beats on Earnings, But Shares Fall on Trading Mix
- RTX Locks In a Decade of Defense Dominance
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
